Benefits of Breast Cancer Index

Susan K. Boolbol, MD

Video Categories: PMO Interview with the Innovator Series: Volume 8

Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.

Related Videos

September 13, 2018

Genetic vs Genomic Testing: What’s the Difference?

Dr Andrey Antov provides a useful metaphor to explain how genetic testing and genomic testing differ from one another and the purpose behind each type of testing.

October 14, 2014

Treatment Approach with Hydoxyurea

Laura C. Michaelis, MD, Medical College of Wisconsin describes the approach of treating polycythemia vera with hydoxyurea.Supported through funding from Incyte